Effect of ribociclib on productivity losses due to breast cancer in young women in Brazil
ABSTRACT OBJETIVE To evaluate the effect of ribociclib versus endocrine therapy on productivity losses due to advanced breast cancer. METHODS Productivity data from the MONALEESA-7 trial, obtained from the results of the application of the Work Productivity and Activity Impairment (WPAI) questionnai...
Saved in:
Main Authors: | Anna Maria Buehler (Author), Pierre-Alexandre Dionne (Author), David Chandiwana (Author), Purnima Pathak (Author), Ebuwa Igho-Osagie (Author) |
---|---|
Format: | Book |
Published: |
Universidade de São Paulo,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ribociclib-Induced Vitiligo: A Case Report
by: Nicolás Silvestre Torner, et al.
Published: (2022) -
Cost-effectiveness of Ribociclib in HER2- negative breast cancer: A synthesis of current evidence
by: Wedad H. Alotaibi, et al.
Published: (2022) -
Differences in metabolic transport and resistance mechanisms of Abemaciclib, Palbociclib, and Ribociclib
by: Zhimin Zhu, et al.
Published: (2023) -
PHARMACOECONOMIC EVALUATION OF RIBOCICLIB FOR THE FIRST-LINE TREATMENT OF HR-POSITIVE HER2-NEGATIVE ADVANCED BREAST CANCER
by: N. A. Avksentyev, et al.
Published: (2018) -
WXJ-202, a novel Ribociclib derivative, exerts antitumor effects against breast cancer through CDK4/6
by: Jing Ji, et al.
Published: (2023)